Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.

Miedlich S, Krohn K, Lamesch P, Müller A, Paschke R.

Eur J Endocrinol. 2000 Jul;143(1):47-54.

2.

Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.

Karges W, Jostarndt K, Maier S, Flemming A, Weitz M, Wissmann A, Feldmann B, Dralle H, Wagner P, Boehm BO.

J Endocrinol. 2000 Jul;166(1):1-9.

3.

Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.

Carling T, Correa P, Hessman O, Hedberg J, Skogseid B, Lindberg D, Rastad J, Westin G, Akerström G.

J Clin Endocrinol Metab. 1998 Aug;83(8):2960-3.

PMID:
9709976
4.

Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.

Dwight T, Twigg S, Delbridge L, Wong FK, Farnebo F, Richardson AL, Nelson A, Zedenius J, Philips J, Larsson C, Teh BT, Robinson B.

Clin Endocrinol (Oxf). 2000 Jul;53(1):85-92.

PMID:
10931084
5.

Somatic mutation of the MEN1 gene in parathyroid tumours.

Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ.

Nat Genet. 1997 Aug;16(4):375-8.

PMID:
9241276
6.

Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.

Scarpelli D, D'Aloiso L, Arturi F, Scillitani A, Presta I, Bisceglia M, Cristofaro C, Russo D, Filetti S.

J Endocrinol Invest. 2004 Dec;27(11):1015-21.

PMID:
15754732
7.

MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.

Cetani F, Pardi E, Vignali E, Borsari S, Picone A, Cianferotti L, Ambrogini E, Miccoli P, Pinchera A, Marcocci C.

J Endocrinol Invest. 2002 Jun;25(6):508-12.

PMID:
12109621
8.

Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.

Newey PJ, Nesbit MA, Rimmer AJ, Attar M, Head RT, Christie PT, Gorvin CM, Stechman M, Gregory L, Mihai R, Sadler G, McVean G, Buck D, Thakker RV.

J Clin Endocrinol Metab. 2012 Oct;97(10):E1995-2005. doi: 10.1210/jc.2012-2303.

9.

Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism.

Pannett AA, Kennedy AM, Turner JJ, Forbes SA, Cavaco BM, Bassett JH, Cianferotti L, Harding B, Shine B, Flinter F, Maidment CG, Trembath R, Thakker RV.

Clin Endocrinol (Oxf). 2003 May;58(5):639-46.

PMID:
12699448
10.

Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.

Cetani F, Pardi E, Giovannetti A, Vignali E, Borsari S, Golia F, Cianferotti L, Viacava P, Miccoli P, Gasperi M, Pinchera A, Marcocci C.

Clin Endocrinol (Oxf). 2002 Apr;56(4):457-64.

PMID:
11966738
11.

Absence of somatic RET gene mutation in sporadic parathyroid tumors and hyperplasia secondary to uremia, and absence of somatic Men1 gene mutation in MEN2A-associated hyperplasia.

Uchino S, Noguchi S, Nagatomo M, Sato M, Yamashita H, Yamashita H, Watanabe S, Murakami T, Toda M, Wakiya S, Adachi M.

Biomed Pharmacother. 2000 Jun;54 Suppl 1:100s-103s.

PMID:
10915003
12.

Familial isolated primary hyperparathyroidism--a multiple endocrine neoplasia type 1 variant?

Miedlich S, Lohmann T, Schneyer U, Lamesch P, Paschke R.

Eur J Endocrinol. 2001 Aug;145(2):155-60. Review.

13.

MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.

Alvelos MI, Vinagre J, Fonseca E, Barbosa E, Teixeira-Gomes J, Sobrinho-Simões M, Soares P.

Eur J Endocrinol. 2012 Dec 31;168(2):119-28. doi: 10.1530/EJE-12-0327.

14.

Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours.

Bergman L, Boothroyd C, Palmer J, Grimmond S, Walters M, Teh B, Shepherd J, Hartley L, Hayward N.

Br J Cancer. 2000 Oct;83(8):1003-8.

15.

Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors.

Uchino S, Noguchi S, Sato M, Yamashita H, Yamashita H, Watanabe S, Murakami T, Toda M, Ohshima A, Futata T, Mizukoshi T, Koike E, Takatsu K, Terao K, Wakiya S, Nagatomo M, Adachi M.

Cancer Res. 2000 Oct 1;60(19):5553-7.

16.

Germline and somatic mutation of the gene for multiple endocrine neoplasia type 1 (MEN1).

Marx SJ, Agarwal SK, Kester MB, Heppner C, Kim YS, Emmert-Buck MR, Debelenko LV, Lubensky IA, Zhuang Z, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL, Alexander RH, Liotta LA, Collins FS, Chandrasekharappa SC, Spiegel AM, Burns AL.

J Intern Med. 1998 Jun;243(6):447-53.

17.

Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.

Farnebo F, Teh BT, Dotzenrath C, Wassif WS, Svensson A, White I, Betz R, Goretzki P, Sandelin K, Farnebo LO, Larsson C.

Hum Genet. 1997 Mar;99(3):342-9.

PMID:
9050920
18.

Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.

Pardi E, Marcocci C, Borsari S, Saponaro F, Torregrossa L, Tancredi M, Raspini B, Basolo F, Cetani F.

J Clin Endocrinol Metab. 2013 Jul;98(7):2800-10. doi: 10.1210/jc.2012-4029.

PMID:
23633209
19.

Identification of somatic mutations in parathyroid tumors using whole-exome sequencing.

Cromer MK, Starker LF, Choi M, Udelsman R, Nelson-Williams C, Lifton RP, Carling T.

J Clin Endocrinol Metab. 2012 Sep;97(9):E1774-81. doi: 10.1210/jc.2012-1743.

PMID:
22740705
20.

Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis.

Poncin J, Stevenaert A, Beckers A.

Eur J Endocrinol. 1999 Jun;140(6):573-6.

Items per page

Supplemental Content

Support Center